Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

FOLFOX before surgey compared to risk-adapted chemotherapy after surgery in patients with locally advanced rectal cancer and low risk for lo… Recruiting

2024-518077-34-00 locally advanced rectal cancer 5 2020-09-30
Midostaurin + Gemtuzumab Ozogamicin combination in first-line standard therapy for acute myeloid leukemia (MOSAIC) Recruiting

2024-514014-13-00 female and male adult patients with acute myeloid leuke 9 2020-09-02
ProTarget - A Danish Nationwide Clinical Trial on Targeted Anti‐Cancer Treatment based on Genomic Profiling Recruiting

2023-510527-29-00 Cancer 4 2020-09-01
A clinical study of the safety and effectiveness of an investigational cell therapy given with and without an investigational RNA-based vacc… Recruiting

2024-514962-38-00 Solid Tumors 1 2020-08-25
Clinical trial to evaluate safety and effectiveness of APL-101 for the treatment of advanced MET expressing solid tumors, including Non-Smal… Recruiting

2024-514542-37-00 Select advanced solid tumors and Non-Small Cell Lung Ca 9 2020-08-13
Treatment of patients with solid tumors with genetically modified patients' own T-cells, recognizing a particular tumor marker Recruiting

2024-515114-41-00 Solid tumors 7 2020-08-10
Multicentre, randomized, controlled, open-label, multi-centre medicoeconomic study evaluating the efficacy of adding zoledronic acid or deno… Recruiting

2024-513248-27-00 Patients, men or women over 18 old, with inoperable ver 5 2020-07-20
An international trial for children with atypical teratoid/rhabdoid tumours (ATRT) Recruiting

2022-501456-28-00 atypical teratoid/rhabdoid tumours (ATRT) 5 2020-07-20
A study to test different doses of obrixtamig (BI 764532) in patients with small cell lung cancer and other neuroendocrine tumours that are … Recruiting

2024-513100-34-00 Small Cell Lung Carcinoma and other neuroendocrine neop 1 2020-07-15
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia Recruiting

2022-501050-11-01 Acute Lymphoblastic Leukaemia 10 2020-07-13
Randomized phase 3 trial comparing FOLFOX to gemcitabine in metastatic first-line in patients with pancreatic adenocarcinoma and non-fit for… Recruiting

2024-511904-18-00 Pancreatic adenocarcinoma (PAC) 10 2020-07-08
Selinexor, Dexamethasone and Bortezomib in Patients with Multiple Myeloma Recruiting

2024-511608-18-00 Penta-refractory multiple myeloma and triple-class refr 4 2020-06-25
A Phase II trial aiming to assess the safety and activity of the combination of cabozantinib plus lanreotide in gastroenteropancreatic (GEP)… Recruiting

2024-516612-16-00 gastroenteropancreatic (GEP) and thoracic neuroendocrin 4 2020-06-17
Clinical trial evaluating the value of treatment with therapy specifically targeting the molecular alterations identified in the tumor of pa… Recruiting

2023-510567-35-00 Advanced / metastatic cancers 4 2020-06-10
Phase 1/2a Clinical Trial of BI-1206, a Monoclonal Antibody to CD32b (FcγRIIB), in Combination with Pembrolizumab in Subjects with Advanced … Recruiting

2023-509846-36-00 Advanced Solid Tumors 9 2020-05-29
Safety and Early Signs of Efficacy of IL12-L19L19 Recruiting

2024-510841-32-00 Advanced or metastatic carcinomas after previous immune 1 2020-05-27
Teicoplanin as Infection Prophylaxis in Pediatric Acute Myeloid Leukemia (Pro-Teico study) Recruiting

2023-506546-23-00 Acute myeloid leukemia 5 2020-05-20
Pan tumor Roll Over Study Recruiting

2023-506914-32-00 Pan tumor 4 2020-05-05
Phase 1 study of a Propranolol (HEMANGIOL®) and oral metronomic Vinorelbine (NAVELBINE®) combination on children and teenagers With Refracto… Recruiting

2024-517185-42-00 Children and teenagers with refractory/relapsing solid 3 2020-05-04
PiSCATIN - Simvastatin for the treatment of primary sclerosing cholangitis (PSC) - a randomized double-blind, placebo-controlled multicenter… Recruiting

2024-511053-22-00 Primary sclerosing cholangitis (PSC) 4 2020-05-04
Phase 1/2a Open-Label, Dose-Escalation, Multicenter, First-in-Human, Consecutive-Cohort, Clinical Trial of BI-1808, a Monoclonal Antibody to… Recruiting

2023-509847-29-00 Advanced solid tumors 7 2020-04-09
MRI with hyperpolarized pyruvate in gliblastoma - a phase II study Recruiting

2024-515408-37-00 glioblastoma multiforme 4 2020-04-01
Multicentric phase III trial comparing two strategies in intermediate-risk differentiated thyroid cancer patients: Systematic radioiodine ad… Recruiting

2024-514603-34-00 intermediate-risk differentiated thyroid cancer patient 5 2020-03-02
A multicentre trial evaluating the combination of a MEK inhibitor and a PDL1 inhibitor in pediatric and adult patients with locally advance… Recruiting

2024-510712-75-00 advanced / metastatic 9 2020-02-12